← All organizations

Alvine Pharmaceuticals Inc.

Alvine Pharmaceuticals Inc.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 1, 2013

Acquired by Immunogen → AbbVie on Mar 1, 2016

Timeline

2000s

Jan 1, 2006
Alvine Pharmaceuticals Inc.— Founded

2010s

Mar 1, 2016
Immunogen— Acquired By

2020s

Nov 30, 2023
AbbVie— Now

Drugs by trial phase (1 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

latiglutenase

Indications

Studied for

Celiac Disease

Recent trials (6)

NCT01917630Study directorPhase 2Aug 1, 2013
NCT01917630Lead sponsorPhase 2Aug 1, 2013
NCT01255696Lead sponsorPhase 2Nov 1, 2010
NCT00959114Lead sponsorPhase 2Aug 1, 2009
NCT00669825Lead sponsorPhase 1Mar 1, 2008
NCT00626184Lead sponsorPhase 1Feb 1, 2008

Details

Founded: Cambridge, Massachusetts, US Jan 1, 2006
Last known activity: Aug 1, 2013